Clinical trials
Recruiting Phase 3 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| National Cancer Institute (NCI) | 1 |
| RemeGen Co., Ltd. | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 1 |
| UroGen Pharma Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 9 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma | 1 |
| Female Urogenital Diseases | 1 |
| Male Urogenital Diseases | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Neoplasms by Site | 1 |
| Urinary Bladder Diseases | 1 |
| Urogenital Diseases | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.